Innovate Transdermal GFR System Receives FDA Approval to Assess Kidney Function

 

• Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function
• The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity
• More than 800 million people have Chronic Kidney Disease (CKD), one of the world’s leading causes of mortality worldwide, with associated deaths increasing over the past two decades

https://www.globenewswire.com/news-release/2025/01/17/3011737/0/en/MediBeacon-Transdermal-GFR-System-Receives-FDA-Approval-to-Assess-Kidney-Function.html